Recombinant vaccinia viruses expressing immunoglobulin variable regions efficiently and selectively protect mice against tumoral B-cell growth.

The variable regions of the immunoglobulin (Ig) expressed on the surface of a malignant B cell can be considered tumor-specific antigens and, as such, could be targets for immunotherapeutic approaches. However, because until now the immunization procedures have been complex and have given only partial protection, it was necessary to find new methods of immunotherapy. Here, we present a successful method of vaccination against B-cell tumors in a murine model. We produced recombinant vaccinia viruses (rVV) expressing the heavy and the light chain of surface Ig of a patient's malignant B cells and we tested the ability of these rVV to protect immunized mice against tumor growth of transfectomas producing the same human Ig. The protection of the mice was complete and specific to the variable region of the immunizing heavy chain although specific lymphoproliferative and cytotoxic responses were not detectable in vitro. The protection was strictly dependent on the presence of CD4 T cells and asialo GM1+ cells. Furthermore, tumor protection clearly required gamma-interferon and was partially inhibited by blocking the Fas-Fas ligand interaction. We also show, in a murine syngeneic model, that rVV expressing a poorly mutated Ig protects against the growth of Ig-producing tumor.

Neurological soft signs in schizophrenia.

A standardised clinical examination which focused on neurological soft signs (NSS) was used by a neurologist blind to diagnosis to assess the presence of neurological soft signs. A comparison of NSS score was made among three groups of subjects consisting of 58 DSM-III schizophrenics, 31 of their healthy first-degree relatives and 38 normal controls. The schizophrenic group had significantly higher NSS total scores than normal controls but did not differ significantly from their first-degree relatives' group. The relatives' group showed higher NSS total scores than did normal controls although to a lesser extent than schizophrenics.

Dementia in schizophrenia. Magnetic resonance and clinical correlates.

Thirty-nine patients with a chronic schizophrenic disorder and 29 healthy control subjects were examined by means of multiplanar magnetic resonance imaging. Schizophrenics as a group showed increased ventricular brain ratio and reduced corpus callosum area. When patients were grouped according to their performance on the Luria-Nebraska Neuropsychological Battery (LNNB), a distinct subgroup of six patients emerged. These patients failed to perform neuropsychological testing, due to their inability to fulfill the instructions, despite often repeated full explanations of the test procedures; four of these patients had enlarged lateral ventricles and all met operational criteria for Kraepelin's dementia praecox. Two other patients subgroups were categorized as LNNB normal and abnormal. These two subgroups showed lesser brain abnormalities and lower negative symptom scores than the former.